Related references
Note: Only part of the references are listed.Methylation of RASSF1A gene promoter is regulated by p53 and DAXX
Hailong Zhang et al.
FASEB JOURNAL (2013)
Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation
Jun Tang et al.
PLOS ONE (2013)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Shinichi Yachida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer
Sheng Wang et al.
DIAGNOSTIC PATHOLOGY (2012)
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
Roeland F. de Wilde et al.
MODERN PATHOLOGY (2012)
How much do you know about benign, preneoplastic, non-invasive and invasive neoplastic lesions of the urinary bladder classified according to the 2004 WHO scheme?
Rodolfo Montironi et al.
DIAGNOSTIC PATHOLOGY (2011)
GLOBAL ACETYLATION AND METHYLATION CHANGES PREDICT PAPILLARY UROTHELIAL NEOPLASIA OF LOW MALIGNANT POTENTIAL RECURRENCE: A QUANTITATIVE ANALYSIS
R. Mazzucchelli et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3
Pascal Drane et al.
GENES & DEVELOPMENT (2010)
New chaps in the histone chaperone arena
Eric I. Campos et al.
GENES & DEVELOPMENT (2010)
A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer
M. Ulrika Segersten et al.
BJU INTERNATIONAL (2009)
Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors
Margaret A. Knowles
FUTURE ONCOLOGY (2008)
Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation
Lorena A. Puto et al.
GENES & DEVELOPMENT (2008)
IMMUNOHISTOCHEMICAL EVALUATION OF GLOBAL DNA METHYLATION AND H I STONE ACETYLATION IN PAPILLARY UROTHELIAL NEOPLASM OF LOW MALIGNANT POTENTIAL
F. Barbisan et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2008)
A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx
Akihide Ryo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Molecular markers for bladder cancer: the road to a multimarker approach
Marc Birkhahn et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer
Anne B. Als et al.
CLINICAL CANCER RESEARCH (2007)
Genomic DNA methylation: the mark and its mediators
RJ Klose et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001
Truls Gardmark et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2006)
Global histone acetylation and deacetylation in yeast
M Vogelauer et al.
NATURE (2000)
Share Paper
